Public Market Listing
Live quotes, historical charts, and market capitalization for Ono Pharmaceutical are available on Yahoo Finance.
View quote & market cap on Yahoo Finance ↗External market data link · No third-party exchange redistribution
Assets
(16 total)
| Target & Modality | |||
|---|---|---|---|
| Approved | MEK1/2Small molecule | Non-Small Cell Lung CancerMelanoma | |
| Approved | ProteasomeSmall molecule | Multiple Myeloma | |
Cenobamate(Xcopri) | Approved | Sodium channels + GABA-A receptorsSmall molecule | Epilepsy Focal Onset Seizures |
Dapagliflozin(Farxiga / Forxiga) | Approved | SGLT2Small molecule | Type 2 DiabetesHeart FailureChronic Kidney DiseaseAtherosclerotic Cardiovascular Disease |
| Approved | BRAF V600ESmall molecule | Non-Small Cell Lung CancerColorectal CancerMelanoma Metastatic Colorectal Cancer, Advanced Metastatic Colorectal Cancer | |
Etelcalcetide(Parsabiv) | Approved | Calcium-sensing receptor (CaSR), allosteric agonist on parathyroid chief cellsPeptide | Chronic Kidney Disease Secondary Hyperparathyroidism |
| Approved | CTLA-4 antagonistMonoclonal antibody | Non-Small Cell Lung CancerHepatocellular CarcinomaColorectal CancerBladder / Urothelial CancerRenal Cell CarcinomaMelanomaEsophageal Cancer Urothelial Carcinoma, Metastatic Colorectal Cancer, Esophageal Squamous Cell Carcinoma, Cutaneous Melanoma, Advanced Metastatic Colorectal Cancer | |
| Approved | PD-1Monoclonal antibody | Non-Small Cell Lung CancerHepatocellular CarcinomaColorectal CancerGastric CancerHead and Neck Squamous Cell CarcinomaBladder / Urothelial CancerRenal Cell CarcinomaMelanomaEsophageal Cancer Urothelial Carcinoma, Metastatic Colorectal Cancer, Esophageal Squamous Cell Carcinoma, Advanced Metastatic Colorectal Cancer | |
Opicapone(Ongentys) | Approved | COMTSmall molecule | Parkinson's Disease |
| Approved | LAG-3Monoclonal antibody | Non-Small Cell Lung CancerMelanoma | |
Sitagliptin(Januvia) | Approved | DPP-4Small molecule | Type 2 Diabetes |
| Phase 3 | Prostaglandin E2 receptor 4 (EP4)Small molecule | Non-Small Cell Lung CancerGastric Cancer | |
| Phase 2 | Endocannabinoid synthesisSmall molecule | Fibromyalgia | |
| Phase 2 | Epigenetic regulation (target undisclosed)Small molecule | Alzheimer's Disease | |
| Phase 1 | Undisclosed / early pipelineSmall molecule | Chronic Kidney Disease |
Upcoming events
(30 total)
Estimated primary-completion dates from ClinicalTrials.gov and expected earnings reports. These are registry estimates, never confirmed readout dates; they can move as trials progress.
Add these trial readouts to your calendar: Apple or Outlook · Google Calendar · .ics link. The calendar updates when a registry date moves.
2026 (2)
December 2026 (2)
What to watch
2027 (9)
January 2027 (2)
February 2027 (1)
What to watch
March 2027 (2)
April 2027 (1)
What to watch
June 2027 (1)
What to watch
August 2027 (1)
December 2027 (1)
What to watch
2028 (5)
February 2028 (2)
March 2028 (1)
What to watch
July 2028 (1)
What to watch
2029 (9)
January 2029 (3)
July 2029 (1)
August 2029 (1)
What to watch
October 2029 (1)
What to watch
November 2029 (1)
What to watch
2030 (2)
2031 (3)
January 2031 (1)
February 2031 (1)
Regulatory and conference events
(7)
Filings, regulator decisions, scientific presentations, topline results and licensing deals, each from a dated source. When a source gives only the month, the month is shown.
Coming up
Recent